News
He was talking about the biotechnology company ImmunityBio. EF Hutton analyst Jason Kolbert initiated coverage of ImmunityBio ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback